Showing results (161-170 of 206) with videos related to

Sort By:
Pageof 21
The Journal of Pathology. Clinical Research|March 6, 2025
Oncocytic and spindle cell typical carcinoids of lung: different immunophenotype and biological behaviorGiovanna Sabella, Giovanni Centonze, Patrick Maisonneuve, et al.
JCO Precision Oncology|April 27, 2022
ALK Inhibitors in Patients With ALK Fusion-Positive GI Cancers: An International Data Set and a Molecular Case SeriesMargherita Ambrosini, Marzia Del Re, Paolo Manca, et al.
JCO Precision Oncology|November 10, 2022
Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver MetastasesFederica Marmorino, Michele Prisciandaro, Mirella Giordano, et al.
European Journal of Cancer (Oxford, England : 1990)|August 11, 2024
Sunitinib for the treatment of patients with advanced pheochromocytomas or paragangliomas: The phase 2 non-randomized SUTNET clinical trialVincenzo Nasca, Natalie Prinzi, Jorgelina Coppa, et al.
Histopathology|October 14, 2022
Lung carcinoid tumours: histology and Ki-67, the eternal rivalryGiovanni Centonze, Patrick Maisonneuve, Michele Simbolo, et al.
Future Oncology (London, England)|June 12, 2025
Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinomaSimone Oldani, Natalie Prinzi, Federica Morano, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2018
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferaseSarit Schwartz, Chris Szeto, Yuan Tian, et al.
Nature Immunology|April 27, 2021
Heme catabolism by tumor-associated macrophages controls metastasis formationFrancesca Maria Consonni, Augusto Bleve, Maria Grazia Totaro, et al.
European Journal of Cancer (Oxford, England : 1990)|June 20, 2020
Prognostic impact of immune-microenvironment in colorectal liver metastases resected after triplets plus a biologic agent: A pooled analysis of five prospective trialsRoberto Moretto, Salvatore Corallo, Antonino Belfiore, et al.
Pageof 21